Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal

Journal of Medical Virology

Volumn 85, Issue 8, 2013, Pages 1409-1413

  Marinho Dias, Joana ^a,b   Ribeiro, Joana ^a,c   Monteiro, Paula ^a   Loureiro, Joana ^a   Baldaque, Inês ^a   Medeiros, Rui ^a,c   Sousa, Hugo ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^c Res Dept of the Port League Against Cancer Liga Portuguesa Contra O Cancro Nucleo Reg Do Norte   (Portugal)

Author keywords

Cervical cancer; Cervix; Cytomegalovirus (CMV); Epstein Barr Virus (EBV)

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INVASIVE CARCINOMA; LESIONS AND DEFECTS; MAJOR CLINICAL STUDY; PORTUGAL; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX DISEASE;

ADULT; AGE FACTORS; AGED; CERVIX UTERI; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MIDDLE AGED; PORTUGAL; PREVALENCE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; HUMAN PAPILLOMAVIRUS;

EID: 84879145608     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23596     Document Type: Article

References (31)

1. Al-Daraji WI, Smith JH. 2009. Infection and cervical neoplasia: Facts and fiction. Int J Clin Exp Pathol 2:48-64.
2. Broccolo F, Cassina G, Chiari S, Garcia-Parra R, Villa A, Leone BE, Brenna A, Locatelli G, Mangioni C, Cocuzza CE. 2008. Frequency and clinical significance of human beta-herpesviruses in cervical samples from Italian women. J Med Virol 80:147-153.
3. Chan PK, Chan MY, Li WW, Chan DP, Cheung JL, Cheng AF. 2001. Association of human beta-herpesviruses with the development of cervical cancer: Bystanders or cofactors. J Clin Pathol 54:48-53.
4. Chattopadhyay K. 2011. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 17:132-144.
5. Dinc B, Bozdayi G, Biri A, Kalkanci A, Dogan B, Bozkurt N, Rota S. 2010. Molecular detection of cytomegalovirus, herpes simplex virus 2, human papillomavirus 16-18 in Turkish pregnants. Braz J Infect Dis 14:569-574.
6. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
7. Fox-Canale AM, Hope TJ, Martinson J, Lurain JR, Rademaker AW, Bremer JW, Landay A, Spear GT, Lurain NS. 2007. Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology 369:55-68.
8. Gallagher A, Armstrong AA, MacKenzie J, Shield L, Khan G, Lake A, Proctor S, Taylor P, Clements GB, Jarrett RF. 1999. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer 84:442-448.
9. Grce M, Husnjak K, Matovina M, Milutin N, Magdic L, Husnjak O, Pavelic K. 2004. Human papillomavirus, cytomegalovirus, and adeno-associated virus infections in pregnant and nonpregnant women with cervical intraepithelial neoplasia. J Clin Microbiol 42:1341-1344.
10. Higgins CD, Swerdlow AJ, Macsween KF, Harrison N, Williams H, McAulay K, Thomas R, Reid S, Conacher M, Britton K, Crawford DH. 2007. A study of risk factors for acquisition of Epstein-Barr virus and its subtypes. J Infect Dis 195:474-482.
11. Johnsen JI, Baryawno N, Soderberg-Naucler C. 2011. Is human cytomegalovirus a target in cancer therapy? Oncotarget 2:1329-1338.
12. Landers RJ, O'Leary JJ, Crowley M, Healy I, Annis P, Burke L, O'Brien D, Hogan J, Kealy WF, Lewis FA, Doyle CT. 1993. Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix. J Clin Pathol 46:931-935.
13. Lattario F, Furtado YL, Silveira FA, do Val IC, Almeida G, da Costa Carvalho Mda G. 2008. Evaluation of DAPK gene methylation and HPV and EBV infection in cervical cells from patients with normal cytology and colposcopy. Arch Gynecol Obstet 277:505-509.
14. Leung AK, Loong EP, Chan RC, Murray HG, Chang AM. 1989. Prevalence of cytomegalovirus cervical excretion in pregnant women in Hong Kong. Asia Oceania J Obstet Gynaecol 15:77-78.
15. Machida U, Kami M, Fukui T, Kazuyama Y, Kinoshita M, Tanaka Y, Kanda Y, Ogawa S, Honda H, Chiba S, Mitani K, Muto Y, Osumi K, Kimura S, Hirai H. 2000. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 38:2536-2542.
16. Matos A, Moutinho J, Pinto D, Medeiros R. 2005. The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population. Eur J Cancer Prev 14:485-491.
17. McGalie CE, McBride HA, McCluggage WG. 2004. Cytomegalovirus infection of the cervix: Morphological observations in five cases of a possibly under-recognised condition. J Clin Pathol 57:691-694.
18. Missaoui N, Hmissa S, Trabelsi A, Frappart L, Mokni M, Korbi S. 2010. Cervix cancer in Tunisia: Clinical and pathological study. Asian Pac J Cancer Prev 11:235-238.
19. Pagano JS. 2007. Is Epstein-Barr virus transmitted sexually? J Infect Dis 195:469-470.
20. Penkert RR, Kalejta RF. 2011. Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae 2:3.
21. Salcedo Mde M, Silveira GP, Zettler CG. 2008. Immunohistochemical expression of p16 and herpes simplex virus type 2 in squamous intraepithelial lesions and cervical cancer. Rev Bras Ginecol Obstet 30:61-66.
22. Silva J, Ribeiro J, Sousa H, Cerqueira F, Teixeira AL, Baldaque I, Osorio T, Medeiros R. 2011. Oncogenic HPV types infection in adolescents and university women from north Portugal: From self-sampling to cancer prevention. J Oncol 2011:953469.
23. Silver MI, Paul P, Sowjanya P, Ramakrishna G, Vedantham H, Kalpana B, Shah KV, Gravitt PE. 2011. Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India. J Clin Microbiol 49:2435-2439.
24. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R. 2002. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604-1613.
25. Szostek S, Zawilinska B, Klimek M, Kopec J, Kosz-Vnenchak M. 2009a. Is the presence of herpesviruses in cervical secretions a prognostic factor for cervical pathology in HPV-positive women?. Przegl Epidemiol 63:97-101.
26. Szostek S, Zawilinska B, Kopec J, Kosz-Vnenchak M. 2009b. Herpesviruses as possible cofactors in HPV-16-related oncogenesis. Acta Biochim Pol 56:337-342.
27. Tomtishen JP, III 2012. Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). Virol J 9:22.
28. Voog E. 1996. Genital viral infections. Studies on human papillomavirus and Epstein-Barr virus. Acta Derm Venereol Suppl (Stockh) 198:1-55.
29. Woodman CB, Collins SI, Vavrusova N, Rao A, Middeldorp JM, Kolar Z, Kumari A, Nelson P, Young LS, Murray PG. 2005. Role of sexual behavior in the acquisition of asymptomatic Epstein-Barr virus infection: A longitudinal study. Pediatr Infect Dis J 24:498-502.
30. zur Hausen H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.
31. zur Hausen H, Gissmann L, Schlehofer JR. 1984. Viruses in the etiology of human genital cancer. Prog Med Virol 30:170-186.